#### 8.771. A virologist is testing a new antiviral compound on a culture of 1000 virus particles. After applying the compound, 60% of the viruses are neutralized in the first hour. In the second hour, 30% of the remaining viruses are neutralized. How many virus particles remain active after two hours? - Malaeb

Understanding the Context

In a controlled laboratory setup, a virologist administers a new antiviral compound to a culture containing 1,000 virus particles. The treatment is applied and monitored over two consecutive hours:

• First hour: The compound neutralizes 60% of the initial virus population.
  
• Second hour: Of the remaining viruses, 30% are neutralized.

This step-by-step neutralization mirrors real-world antiviral action, where successive mechanisms work to eliminate or suppress viral replication.

Hour-by-Hour Breakdown of Virus Count

Key Insights

1. Initial Count:
Starting number of virus particles = 1,000

2. After First Hour (60% neutralized):
60% of 1,000 = 0.60 × 1,000 = 600 viruses neutralized
Remaining active viruses = 1,000 – 600 = 400

3. After Second Hour (30% of remaining neutralized):
30% of the remaining 400 viruses are neutralized in the second hour:
0.30 × 400 = 120 viruses neutralized
Remaining active viruses = 400 – 120 = 280

Final Result: Active Viruses After Two Hours

After two hours of treatment, 280 virus particles remain active in the culture.

Final Thoughts

Why This Matters

This model illustrates the multiplicative effect of sequential virus neutralization—common in antiviral therapy design. Reducing viral load by 60% early and an additional 30% of the survivors demonstrates how layered antiviral mechanisms can significantly hinder viral spread. Such data guides researchers in optimizing dosage, timing, and compound efficacy.

Conclusion

In antiviral trials, understanding the remaining viral titer after treatment hours helps assess therapeutic potential. In this example, despite a strong initial response, 28% of the original 1,000 virus particles—totaling 280 particles—remain active after two hours. Continued compound refinement could further reduce this residual population, paving the way for more effective treatments.

For scientists and healthcare providers, tracking remaining virus particles is key to evaluating how well a new treatment curbs infection spread—another vital step toward dynamic, evidence-based antiviral development.